Literature DB >> 2371918

Cytochrome P-450 metabolic-intermediate complex formation with a series of diphenhydramine analogues.

A Bast1, A J Valk, H Timmerman.   

Abstract

A series of diphenhydramine analogues have been studied with regard to their formation of a metabolic intermediate (MI) during their biotransformation in phenobarbital induced rat hepatic microsomes. The MI forms a complex with reduced cytochrome P-450. MI complexation of cytochrome P-450 may result in drug-drug interactions and/or in cumulation of the parent compound. The extent of MI complex formation could be correlated with the lipophilicity of the substrates in a parabolic manner. A hydrophobic pocket of limited dimensions in cytochrome P-450 for the N-alkyl substituent of the substrates can be assumed. Moreover our data indicate a role for the O-atom in the diphenhydramine analogues for the interaction with cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2371918     DOI: 10.1007/bf01969027

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Effect of multiple administration of orphenadrine or mono-N-desmethylorphenadrine on cytochrome P-450 catalyzed reactions in the rat.

Authors:  A Bast; E M Savenije-Chapel; F A van Kemenade; L W Scheefhals; J Noordhoek
Journal:  Arch Toxicol       Date:  1983-10       Impact factor: 5.153

2.  Cytochrome P450 product complexes and glutathione consumption produced in isolated hepatocytes by norbenzphetamine and its N-oxidized congeners.

Authors:  M Hirata; B Lindeke; S Orrenius
Journal:  Biochem Pharmacol       Date:  1979       Impact factor: 5.858

3.  Quantitation of two forms of pulmonary cytochrome P-450 in microsomes, using substrate specificities.

Authors:  M R Franklin; C R Wolf; C Serabjit-Singh; R M Philpot
Journal:  Mol Pharmacol       Date:  1980-05       Impact factor: 4.436

4.  Spectral interaction of orphenadrine and its metabolites with oxidized and reduced hepatic microsomal cytochrome P-450 in the rat.

Authors:  A Bast; J Noordhoek
Journal:  Biochem Pharmacol       Date:  1982-09-01       Impact factor: 5.858

5.  Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.

Authors:  L K Pershing; M R Franklin
Journal:  Xenobiotica       Date:  1982-11       Impact factor: 1.908

6.  Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. 8. Stereoselectivity in metabolic intermediary complex formation with a series of chiral 2-substituted 1-phenyl-2-aminoethanes.

Authors:  U B Paulsen-Sörman; K H Jönsson; B G Lindeke
Journal:  J Med Chem       Date:  1984-03       Impact factor: 7.446

7.  Product inhibition in orphenadrine metabolism as a result of a stable cytochrome P-450-metabolic intermediate complex formed during the disposition of mono-N-desmethylorphenadrine (tofenacine) in the rat.

Authors:  A Bast; F A van Kemenade; E M Savenije-Chapel; J Noordhoek
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-06

8.  Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.

Authors:  D Larrey; M Tinel; D Pessayre
Journal:  Biochem Pharmacol       Date:  1983-05-01       Impact factor: 5.858

9.  Relationship between molecular structure and cytochrome P450-metabolic intermediate complex formation, studied with orphenadrine analogues.

Authors:  A Bast; E M Savenije-Chapel; J Noordhoek
Journal:  J Pharm Sci       Date:  1984-07       Impact factor: 3.534

10.  Formation of an inactive cytochrome P-450Fe(II)-metabolite complex after administration of amiodarone in rats, mice and hamsters.

Authors:  D Larrey; M Tinel; P Letteron; J Geneve; V Descatoire; D Pessayre
Journal:  Biochem Pharmacol       Date:  1986-07-01       Impact factor: 5.858

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.